Sodium thiosulfate - Dr Franz Koehler Chemie

Drug Profile

Sodium thiosulfate - Dr Franz Koehler Chemie

Latest Information Update: 21 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PromediPharm
  • Developer Dr Franz Kohler Chemie GmbH
  • Class Antidotes; Antituberculars; Chemoprotectants; Thiosulfates
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Calciphylaxis
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Calciphylaxis

Most Recent Events

  • 21 Dec 2016 Sodium thiosulfate is still in phase II/III trials for Calciphylaxis in Switzerland, Austria and Germany (IV, infusion)
  • 01 Oct 2014 Phase-II/III clinical trials in Calciphylaxis in Austria (IV, infusion) (ISRCTN73380053)
  • 01 Oct 2014 Phase-II/III clinical trials in Calciphylaxis in Germany (IV, infusion) (ISRCTN73380053)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top